Postpartum thyroiditis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As Postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis.
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis.


==Differentiating Postpartum Thyroiditis from other Diseases==
==Differentiating Postpartum Thyroiditis from other Diseases==
Line 15: Line 15:
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Age at onset
! style="background:#4479BA; color: #FFFFFF;" |Age of onset (years)
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
Line 22: Line 22:
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-50
*All ages, peak at 30-50
Line 28: Line 28:
*Lymphocytic infiltration
*Lymphocytic infiltration
*Germinal centers
*Germinal centers
*Fibrosis (in some variants)
*[[Fibrosis]] (in some variants)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism)
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 41: Line 41:
*20-60
*20-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Giant cells
*[[Giant cells]]
*Granulomas
*[[Granulomas]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (Thyrotoxicosis)
* [[Thyroid function tests|Decreased TSH]] ([[thyrotoxicosis]])
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[I-123 thyroid imaging|I-123]] uptake decreased
*[[I-123 thyroid imaging|I-123]] uptake decreased
Line 51: Line 51:
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-40
*All ages, peak at 30-40
Line 58: Line 58:
*Lymphoid follicles
*Lymphoid follicles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 65: Line 65:
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Childbearing age
*Childbearing age
Line 71: Line 71:
*Lymphocytic infiltration
*Lymphocytic infiltration
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 82: Line 82:
*30-60
*30-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Dense fibrosis
*Dense [[fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 90: Line 90:
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Infection
*[[Infection]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Children, 20-40
*Children, 20-40
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Abscess formation
*[[Abscess]] formation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 120: Line 120:
|-
|-
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] ([[Hashimoto's thyroiditis]])
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]]  
([[Hashimoto's thyroiditis]])
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 146: Line 147:
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
|-
|-
| align="center" style="background:#DCDCDC;" |[[Infectious thyroiditis]]
| align="center" style="background:#DCDCDC;" |Infectious thyroiditis
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 219: Line 220:
| align="center" style="background:#DCDCDC;" |Trauma induced
| align="center" style="background:#DCDCDC;" |Trauma induced
|-
|-
| align="center" style="background:#DCDCDC;" |Radioiodine induced
| align="center" style="background:#DCDCDC;" |[[Radioiodine]] induced
|-
|-
| align="center" style="background:#DCDCDC;" |Thyroidectomy
| align="center" style="background:#DCDCDC;" |[[Thyroidectomy]]
|-
|-
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
Line 237: Line 238:
|-
|-
|}
|}
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypo]]/[[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypothyroidism]] or [[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''


===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
*Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
*Postpartum thyroiditis can initially present with [[thyrotoxicosis]] which must be differentiated from other causes of [[thyrotoxicosis]].<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
Line 250: Line 251:
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
Line 328: Line 329:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Patient may have opthalmopathy and dermopathy
* Opthalmopathy and [[dermopathy]] may be present
|-
|-
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
Line 357: Line 358:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
Line 372: Line 373:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="2" style="background:#DCDCDC;" |Drug induced
| rowspan="2" style="background:#DCDCDC;" |Drug induced
Line 387: Line 388:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
Line 401: Line 402:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| rowspan="3" style="background:#DCDCDC;" |Others
| rowspan="3" style="background:#DCDCDC;" |Others
Line 416: Line 417:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Decreased thyroglobulin
*Decreased [[thyroglobulin]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]

Revision as of 19:11, 30 October 2017

Postpartum thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Postpartum Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Postpartum thyroiditis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Postpartum thyroiditis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Postpartum thyroiditis differential diagnosis

CDC on Postpartum thyroiditis differential diagnosis

Postpartum thyroiditis differential diagnosis in the news

Blogs on Postpartum thyroiditis differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Postpartum thyroiditis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.

Differentiating Postpartum Thyroiditis from other Diseases

Differentiating postpartum thyroiditis from other causes of thyroiditis

Conditions Causes Age of onset (years) Pathological findings Diagnostic approach
Hashimoto's thyroiditis
  • All ages, peak at 30-50
  • Lymphocytic infiltration
  • Germinal centers
  • Fibrosis (in some variants)
Painful subacute (De Quervain's) thyroiditis
  • Unknown
  • 20-60
Silent thyroiditis
  • All ages, peak at 30-40
  • Lymphocytic infiltration
  • Lymphoid follicles
Postpartum thyroiditis
  • Childbearing age
  • Lymphocytic infiltration
Riedel's thyroiditis
  • Unknown
  • 30-60
Suppurative thyroiditis
  • Children, 20-40

Differentiating postpartum thyroiditis from other causes of hypothyroidism

  • Postpartum thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[4][5][1][6][7][8]
Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TPOAb^
Primary hypothyroidism Autoimmune

(Hashimoto's thyroiditis)

- - * Normal/ Normal/↓ Normal/ Normal Present (high titer)
Riedel's thyroiditis - - Normal/↑ Normal/↓ Normal/↓ Normal/↓ Normal Normal Usually present
Infectious thyroiditis + + Normal Normal Normal Normal Normal Normal Absent
Transient hypothyroidism Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Low/absent
Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Present (high titer)
Silent thyroiditis - - ↑/ ↓/ Normal Normal Present (high titer)
Others Drug-induced - - /↓ /↑ Normal Normal/ Normal Absent**
  • History of hyperthyroidism
  • History of trauma
  • History of drug use, surgery, or radiation
Radiation-induced
Trauma induced
Radioiodine induced
Thyroidectomy
Subclinical hypothyroidism - - Normal Normal Normal Normal Normal Normal/
  • Asymptomatic


(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypothyroidism or hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.

Differentiating postpartum thyroiditis from other causes of thyrotoxicosis

Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TSH Receptor Antibody TPOAb^
Thyroiditis Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Absent Present (high titer)
Hashimoto's thyroiditis (Hashitoxicosis) - - * Normal/ Normal/↓ Normal/ Normal Absent Present (high titer)
Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Absent Low/absent
Silent thyroiditis - - ↑/ ↓/ Normal Normal Absent Present (high titer)
Primary hyperthyroidism Grave's disease - - Normal/ Normal Present Absent
Toxic thyroid nodule - - Normal/↑ ↑(hot nodule) Normal/ Normal Absent Absent

-

Secondary hyperthyroidism Pituitary adenoma - - Normal/↑ Normal/ Normal Absent Absent
  • Inappropriately normal or increased TSH
Tertiary hyperthyroidism Tertiary hyperthyroidism - - Normal/ Absent Absent
  • Inappropriately normal or increased TSH
Drug induced Amiodarone type 1 - - Normal/↑ Normal/ Normal Absent Absent
Amiodarone type 2 - - Normal/↑ Absent/↓ Normal/ Normal Absent Absent
Others Factitious thyrotoxicosis - - Normal/↑ Normal Absent Absent
Trophoblastic disease - - Normal/↑ - Normal Absent Absent

-

Struma ovarii - - Normal/↑ - Normal Absent Absent

-

(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.

Stages Peek

presenting purpural

month

Disease Symptoms and Signs Labs Mechanisum
Fatiuge Neck

swelling

Low

mood

Irritability TSH FT4 TPO ab ESR RAI

U

Thyroid U/S Microscopic

Picture

Persistent

hyperthyroidism

4-6 Grave's disease + Small

painful

mass

Present Present

early

Low High Absent diffusely

enlarged

hypervascular

heterogeneous

echotexture

hyperplastic

follicles due to

eosinophilic

cytoplasm

scalloping

TSHR

activating

antibodies

Transient

hyperthyroidism

2-4 Silent thyroiditis + Small

painless

goiter

Present

late

Present

early

Normal

or Low

High 50% NL markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic

infiltration

Lymphoid

follicles

CD4

T-cell

activation

mutation

Postpartum thyroiditis + Small

painless goiter

Present

late

Present

early

Normal

or Low

High >80%  hypoechoic

diffusely

enlarged

with

normal

or decreased

vasclarity

variable

heterogeneous

texture

hypoechogenic

Reg

T-cell

gain in

function

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

Present

late

Present

early

Normal

or Low

High Absent diffusely

enlarged &

normal or

decreased

 vasclarity

Giant cells

Granulomas

systemic

viral

infections

Factitious

thyrotoxicosis

+ Normal Absent Present

early

Normal

or Low

High Absent NL Normal Normal

histology

thyroixine

intake

acute suppurative

thyroiditis

+ Small

painful

mass

Present

late

Present

early

Normal

or Low

High Absent variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

polymorphonuclear leukocytes

lymphocytes

exudates

infections

viral,bacterial

Destructive

hyperthyroidism

4-6 Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

Present

late

Present

early

Normal

or Low

High Absent diffusely

enlarged

&normal or

decreased

 vasclarity

Giant cells

Granulomas

systemic

viral

infections

Postpartum

thyroiditis

+ Small

painless

goiter

Present

late

Present

early

Normal

or Low

High >80%  hypoechoic

diffusely

enlarged&

normal or

decreased

vasclarity

variable

heterogeneous

texture

hypoechogenic

Reg

T-cell

gain in

function

mutation

acute suppurative

thyroiditis

+ Small

painful

mass

Present

late

Present

early

Normal

or Low

High Absent variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

polymorphonuclear leukocytes

lymphocytes

exudates

infections

viral,bacterial

Transient

hypothyroidism

2-4 Postpartum

thyroiditis

+ Small

painless goiter

Present

late

Present

early

Normal

or High

Low >80%   hypoechoic

diffusely

enlarged

& normal or

decreased

vasclarity

variable

heterogeneous

texture

, hypoechogenic

Reg

T-cell

gain in

function

mutation

Silent

thyroiditis

+ Small

painless goiter

Present

late

Present

early

Normal

or High

Low Present NL markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic infiltration

Lymphoid follicles

CD4

T-cell

activation

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful mass

Present

late

Present

early

Normal

or High

Low Absent diffusely

enlarged

normal or

decreased

 vasclarity

Giant cells

Granulomas

systemic

viral

infections

acute suppurative

thyroiditis

+ Small

painful mass

Present

late

Present

early

Normal

or High

Low Absent variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

polymorphonuclear leukocytes

lymphocytes

exudates

infections

viral,bacterial

Persistent

hypothyroidism

6 Riedel's

thyroiditis

+ Small

painful mass

Present

late

Present

early

High Low 75% homogeneously

hypoechoic

fibrotic

invasion of the

adjacent

structures

 lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue infections

viral,bacterial

Postpartum

thyroiditis

+ Small

painless goiter

Present

late

Present

early

High Low >80%  hypoechoic

diffusely

enlarged&

normal

or decreased

vasclarity

variable

heterogeneous

texture,

hypoechogenic

Reg

T-cell

gain in

function

mutation

Hashimoto's

thyroiditis

+ Painful

mass

Present

late

Present

early

High Low 95% heterogeneous

echotexture

decreased

vasclarity

hypoechoic

micronodules

lymphoid

follicles

Germinal centers

Hurthle cells

Reg T-cell

dysfunction

Acute suppurative

thyroiditis

+ Small

painful mass

Present

late

Present

early

High Low Absent variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

polymorphonuclear leukocytes

lymphocytes

exudates

systemic

viral

infections

References

  1. 1.0 1.1 1.2 "Thyroiditis — NEJM".
  2. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  3. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  4. 4.0 4.1 Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
  5. 5.0 5.1 McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
  6. 6.0 6.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
  7. 7.0 7.1 Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
  8. 8.0 8.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.
  9. "Clinical Finding and Thyroid Function in Women with Struma Ovarii".
  10. Vaidya B, Pearce SH (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. PMID 25146390.
  11. "Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ".

Template:WH Template:WS